Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Recruiting now · Phase 2

Conditions studied: Lymphoblastic Leukemia in Children

In brief

Aim of this study is to investigate the outcome of NGS MRD based risk stratified treatment for high risk acute lymphoblastic leukemia in children and adolescents.

Key facts

Study ID

NCT06099366

Run by

Hee Young Ju

People needed

116

Starts

2024-03-05

Expected to finish

2033-12-31

Last updated by the study team

2026-07-29

Who can join

Age: 1 and older, up to 9. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Ajou University Medical Center — Suwon, South Korea (enrolling)
• Samsung Medical Center — Seoul, Other (Non U.s.), South Korea (enrolling)
• Pusan National University Yangsan Hospital — Yangsan, Yangsan-si, South Korea (enrolling)
• Severance Hospital — Seoul, South Korea (enrolling)
• Seoul saint Mary's Hospital — Seoul, South Korea (enrolling)
• Asan Medical Center — Seoul, Other (Non U.s.), South Korea (enrolling)
• Jeju National University Hospital — Jeju City, South Korea (enrolling)
• Seoul National University Bundang Hospital — Seongnam, South Korea (enrolling)
• Korea University Anam Hospital — Seoul, South Korea (enrolling)
• Seoul National University Hospital — Seoul, South Korea (enrolling)
• Kyungpook National University Chilgok-Hospital — Daegu, South Korea
• Chungnam National University Hospital — Daejeon, South Korea
• Chonnam National University Hwasun Hospital — Hwasun, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.